📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cognitive impairment in the preclinical stage of dementia in FTD-3 CHMP2B mutation carriers: a longitudinal prospective study. (2013)

First Author: Stokholm J

Attributed to: Investigation of the mechanism of CHMP2B-induced neurodegeneration using a novel transgenic mouse model funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/jnnp-2012-303813

PubMed Identifier: 23142962

Publication URI: http://europepmc.org/abstract/MED/23142962

Type: Journal Article/Review

Volume: 84

Parent Publication: Journal of neurology, neurosurgery, and psychiatry

Issue: 2

ISSN: 0022-3050